Butterfly Network Launches New Handheld Ultrasound System
Recently cleared by the FDA, the iQ3 point-of-care ultrasound system reportedly offers new advances in 3D imaging capabilities.
Offering a combination of enhanced image processing, artificial intelligence (AI) tools and improved 3D imaging, the Butterfly Network has unveiled the iQ3TM handheld ultrasound.
In addition to a “no focus” rubber lens that facilitates improved observation of small anatomical structures, the iQ3 point-of-care device also features 3D imaging advances with iQ Slice and iQ Fan.
Butterfly Network said the iQ Slice technology features automated steering of the beam for optimal organ scanning and can capture 46 ultrasound slices simultaneously across a wide angle. With real-time virtual fanning, the iQ Fan provides clinicians with smoother visualization of A-lines and other lung conditions, according to Butterfly Network.
The company added that these 3D imaging advances with the iQ3 device are combined with existing AI tools, six imaging modes and over 20 anatomical presets in Butterfly Network ultrasound devices.
“The introduction of Butterfly iQ3 includes a focus on higher precision capabilities for cardiovascular point-of-care ultrasound applications to inform complex decisions,” noted Partho Sengupta, M.D., the chief of cardiology at Rutgers Robert Wood Johnson Medical School. “In my early experience, I found that the enhancements in visualization technology and artificial intelligence, as well as image quality will greatly assist health care professionals in our efforts to continually improve outcomes for our patients.”
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Clears Point-Of-Care Ultrasound Platform and AI Software for Neuraxial Procedures
July 17th 2025The dual FDA clearances for the Accuro 3S point-of-care ultrasound device and the SpineNav-AI machine learning-based software may enhance precision and safety with ultrasound-guided neuraxial procedures.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
